Article Type : Case Report
Authors : Tuwei Y, Mathew M, Senfat P and Kumar P
Keywords : Severe hypomagnesaemia, Electrolyte, Hypokalaemia
Severe
hypomagnesaemia is an important but frequently under-recognised electrolyte
disturbance that may result in refractory hypokalaemia, metabolic
abnormalities, and clinically significant cardiac arrhythmias. We report the
case of an 85-year-old woman who presented with profound hypomagnesaemia,
hypokalaemia, bradyarrhythmia, and normal anion gap metabolic acidosis.
Electrocardiography demonstrated atrial fibrillation with a slow ventricular
response and QT prolongation. Biochemical findings raised suspicion for renal
tubular acidosis, and the presence of trace glycosuria suggested a possible
proximal tubular process, including Type 2 renal tubular acidosis or partial
Fanconi syndrome. The patient was treated with intravenous and oral magnesium,
potassium supplementation, and sodium bicarbonate therapy, with subsequent
clinical and biochemical improvement. This case highlights the critical role of
magnesium in potassium homeostasis and cardiac electrophysiology and
underscores the importance of considering renal tubular disorders in patients
with normal anion gap metabolic acidosis and electrolyte wasting.
Hypomagnesaemia is frequently overlooked in clinical practice despite its central role in electrolyte homeostasis and cardiac stability. Magnesium is essential for intracellular potassium regulation and modulates myocardial ion channels. Severe magnesium deficiency may lead to refractory hypokalaemia, conduction abnormalities, QT prolongation, and increased risk of malignant arrhythmias [1,2]. Normal anion gap metabolic acidosis in the presence of hypokalaemia should prompt evaluation for renal tubular acidosis. Proximal renal tubular acidosis may occur in isolation or as part of a broader proximal tubular disorder such as Fanconi syndrome [3,4]. In elderly patients, these conditions may be multifactorial and frequently under-recognised.
Case Presentation
An 85-year-old woman was admitted for evaluation of
significant electrolyte abnormalities identified during routine testing. She
reported generalised weakness, fatigue, and reduced oral intake. There was no
history of diarrhoea, vomiting, or other gastrointestinal losses.
On examination, she was
haemodynamically stable. However, during early admission, she developed marked
bradycardia, with heart rates recorded between 30 and 40 beats per minute. She
did not report syncope or chest pain but was considered at high risk for
arrhythmic complications.
Investigations
Initial laboratory investigations demonstrated severe
electrolyte abnormalities. Serum magnesium was markedly reduced, ranging from
0.30 to 0.50 mmol/L. Serum potassium ranged from 3.0 to 3.3 mmol/L. Serum
bicarbonate was reduced at 17–20 mmol/L, and the anion gap was normal. Serum
sodium ranged from 134 to 136 mmol/L. Renal function was relatively preserved,
with an estimated glomerular filtration rate of approximately 50–60 mL/min/1.73
m². Serum lactate was normal. Venous blood gas analysis demonstrated a pH of 7.27,
pCO? of 48 mmHg, bicarbonate of 22 mmol/L, and base excess of ?5 mmol/L,
consistent with metabolic acidosis. Venous blood gas demonstrating acidemia with reduced
bicarbonate and negative base excess consistent with metabolic acidosis (Tables
1-3).
Electrocardiography demonstrated atrial fibrillation
with a slow ventricular response. Subsequent tracings showed QT prolongation,
with a corrected QT interval of approximately 512 milliseconds (Figure 1). A prior transthoracic echocardiogram demonstrated
atrial fibrillation, mildly reduced left ventricular systolic function (LVEF
51%), regional wall motion abnormalities, and moderate biatrial enlargement.
Right ventricular function was preserved. Urinalysis demonstrated a urine pH of 6, no
proteinuria, and trace glycosuria. There was no evidence of infection. The
presence of glycosuria in the absence of significant hyperglycaemia raised
suspicion for proximal tubular dysfunction (Figure 2).
Figure 1: ECG – Atrial fibrillation with slow ventricular response.
Figure 2: Telemetry – QT prolongation.
Differential Diagnosis
The differential diagnosis included proximal (Type 2) renal tubular acidosis, distal (Type 1) renal tubular acidosis, renal magnesium wasting syndromes, drug-induced tubular dysfunction, and gastrointestinal bicarbonate loss. The coexistence of normal anion gap metabolic acidosis, hypokalaemia, severe hypomagnesaemia, and trace glycosuria strongly suggested a renal tubular process. The presence of glycosuria supported a proximal tubular defect, including possible Type 2 renal tubular acidosis or partial Fanconi syndrome. Distal renal tubular acidosis was considered less likely in the absence of persistently alkaline urine or nephrolithiasis. Gastrointestinal bicarbonate loss was considered unlikely given the absence of relevant clinical features.
Diagnostic Approach
Diagnostic Algorithm for patient with Metabolic acidosis
Step 1: Confirm metabolic acidosis with low pH and low
bicarbonate
Step 2: Calculate anion gap ? normal
Step 3: Assess potassium ? hypokalaemia
Step 4: Differentiate renal vs gastrointestinal causes
using urine anion gap
• Negative ? GI bicarbonate loss
• Positive ? Renal cause (RTA)
Step 5: Measure urine pH
• >5.5 suggests distal RTA
• <5.5 suggests proximal RTA after steady state
Step 6: Evaluate for proximal tubular dysfunction
• Glycosuria
• Phosphaturia
• Uric acid wasting
Step 7: Assess urinary magnesium losses
Conclusion: Hypokalaemia + NAGMA + Mg wasting +
glycosuria
Findings in this case are most consistent with proximal tubular dysfunction (possible Type 2 RTA / Fanconi)
Treatment
The patient was treated with intravenous magnesium
replacement followed by oral supplementation. Potassium replacement was
administered concurrently. Sodium bicarbonate therapy was initiated to correct
metabolic acidosis. Continuous cardiac monitoring was maintained due to
the risk of bradyarrhythmia and ventricular arrhythmias associated with
electrolyte abnormalities and QT prolongation. A medication review was
undertaken to exclude drug-induced causes.
Outcome and follow-up
Following treatment, there was progressive improvement
in serum magnesium and potassium levels. The patient’s heart rate improved,
with resolution of bradycardia. Acid–base status stabilised with bicarbonate
therapy. Clinically, she reported improvement in symptoms, including reduced
fatigue and improved appetite. Further outpatient evaluation was planned to clarify
the underlying tubular disorder. This included urine electrolyte studies, urine
anion gap, fractional excretion of bicarbonate, and a Fanconi screen.
Table 1: Laboratory Trends During Admission.
|
Parameter |
7 Apr 2026 |
9 Apr 2026 |
12 Apr 2026 |
15 Apr 2026 |
Reference Range |
|
Magnesium (mmol/L) |
0.30 |
0.55 |
0.53 |
0.69 |
0.7–1.0 |
|
Potassium (mmol/L) |
3.0–3.2 |
3.6 |
4.7 |
4.5 |
3.5–5.0 |
|
Sodium (mmol/L) |
134–136 |
139 |
136 |
136 |
135–145 |
|
Bicarbonate (mmol/L) |
17–20 |
22 |
23 |
27 |
22–28 |
|
Creatinine (µmol/L) |
~80 |
74 |
69 |
73 |
60–110 |
|
eGFR (mL/min/1.73 m²) |
50–60 |
~65 |
70 |
65 |
>60 |
Table 2: Venous Blood Gas Trends.
|
Date |
pH |
pCO? |
HCO?? |
Base Excess |
Lactate |
|
7 Apr |
7.27 |
48 |
22 |
-5 |
1.5 |
|
9 Apr |
7.29 |
41 |
20 |
-7 |
0.9 |
|
12 Apr |
7.37 |
42 |
24 |
-1.1 |
2.5 |
|
15 Apr |
7.38 |
48 |
28 |
2.5 |
1.3 |
Table 3. Comparison of Renal Tubular Acidosis Subtypes
|
Feature |
Type 1 (Distal
RTA) |
Type 2
(Proximal RTA) |
Type 4 RTA |
|
Primary
defect |
Impaired
H? secretion |
Impaired
HCO?? reabsorption |
Aldosterone
deficiency/resistance |
|
Serum
potassium |
Low |
Low |
High |
|
Urine pH |
>5.5
(persistently) |
Variable
(<5.5 after steady state) |
<5.5 |
|
Anion gap |
Normal |
Normal |
Normal |
|
Bicarbonate
loss |
Mild |
Significant |
Mild |
|
Nephrolithiasis |
Common |
Rare |
Rare |
|
Fanconi
features |
Absent |
May be
present |
Absent |
|
Magnesium
wasting |
Uncommon |
Possible |
Rare |
|
Likelihood
in this case |
Less
likely |
Most
likely |
Unlikely |
.
This case highlights the complex interplay between
magnesium deficiency, potassium homeostasis, renal tubular function, and
cardiac electrophysiology. Magnesium deficiency leads to increased renal
potassium wasting and refractory hypokalaemia by affecting distal tubular
potassium channels [2]. Consequently, potassium replacement alone is often
ineffective until magnesium is corrected. Hypomagnesaemia also has significant cardiac effects.
It predisposes to bradyarrhythmias, QT prolongation, and ventricular arrhythmias
[5]. In this case, the presence of underlying structural heart disease likely
increased susceptibility to these electrophysiological disturbances.
The presence of normal anion
gap metabolic acidosis with preserved renal function suggests renal tubular
acidosis [3]. The finding of trace glycosuria raises suspicion for proximal
tubular dysfunction, as glycosuria in the absence of hyperglycaemia indicates
impaired proximal tubular reabsorption [4,6]. When considered alongside
electrolyte wasting, this supports a diagnosis of proximal tubular dysfunction,
including possible Type 2 renal tubular acidosis or partial Fanconi syndrome.
However, definitive
classification requires further investigations, including urine anion gap,
urine pH during acidosis, and bicarbonate handling studies. In the absence of
these data, the diagnosis should be described as suspected proximal tubular
dysfunction.
This case describes severe hypomagnesaemia with refractory hypokalaemia, bradyarrhythmia, and normal anion gap metabolic acidosis in an elderly woman. The findings are most consistent with renal tubular dysfunction, likely involving a proximal tubular process such as possible Type 2 renal tubular acidosis or partial Fanconi syndrome. Early recognition and correction of magnesium deficiency were essential in preventing potentially life-threatening complications.
Learning points